BNP Paribas Asset Management’s Astrana Health ASTH Stock Holding History
Bought
Maintained
Sold
Other funds holding ASTH
3C
BNP Paribas Asset Management's ASTH Position: Q2 2026 in Review
BNP Paribas Asset Management reduced its Astrana Health (ASTH) stake by 56% in Q2 2026, selling an estimated $7.1M and leaving 154,327 shares worth $7.16M. The position accounts for 0.01% of the portfolio, ranked #800.
BNP Paribas Asset Management first reported a position in ASTH in Q2 2025 and has held it in 5 quarters since. The position peaked at $8.62M in Q1 2026. 209 funds tracked by Wall St. Rank hold ASTH as of Q2 2026.
- BNP Paribas Asset Management held 154,327 shares of Astrana Health worth $7.16M as of Q2 2026.
- BNP Paribas Asset Management sold 197,303 Astrana Health shares in Q2 2026, an estimated $7.1M.
- Astrana Health made up 0.01% of BNP Paribas Asset Management's portfolio in Q2 2026, its #800 holding.
- BNP Paribas Asset Management first reported a position in Astrana Health in Q2 2025 and has held it in 5 quarters since.
- BNP Paribas Asset Management's Astrana Health position peaked at $8.62M in Q1 2026.
- 209 funds tracked by Wall St. Rank held Astrana Health as of Q2 2026.
Based on BNP Paribas Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.